Dendrobium luminous pills, clarithromycin sustained-release tablets, azlocillin sodium for injection, compound honeysuckle granules, prepared radix aconiti, rhodiola, radix peucedani and radix gentianae macrophyllae. For drugs that do not meet the requirements, the drug supervision and administration department has asked relevant enterprises and units to take risk control measures such as suspension of sales and use and recall. Investigate the causes of non-compliance and seriously rectify the non-compliance drugs. After inspection by Guangxi Food and Drug Inspection Institute, the 12 batches of Dendrobium luminous pills produced by Jilin Tonghua Xiang Bo Pharmaceutical Co., Ltd., Jilin Shuangshi Pharmaceutical Co., Ltd. and Jilin Tiantai Pharmaceutical Co., Ltd. were determined to be unqualified. After inspection by Shanxi Food and Drug Inspection Institute, 1 batch of clarithromycin sustained-release tablets labeled as Hainan Puli Pharmaceutical Co., Ltd. did not meet the requirements, and the unqualified item was loss on drying. The 1 batch of azlocillin sodium for injection labeled as Shanxi Ganyuan Pharmaceutical Group Co., Ltd. did not meet the requirements after inspection by Fujian Food and Drug Quality Inspection Institute, and the unqualified item was the clarity of the solution. The two batches of compound honeysuckle granules labeled as Hebei Guo Jin Pharmaceutical Co., Ltd. and Guangzhou Huacheng Pharmaceutical Co., Ltd. did not meet the requirements after inspection by the Institute for Drug Control of Inner Mongolia Autonomous Region, and the items that did not meet the requirements were quantity differences. According to the inspection by Shenzhen Institute for Drug Control and China Institute for Food and Drug Control, the batch of Rhodiola sachalinensis 1 and the batch of Radix Aconiti Preparata 1 produced by Anhui Hua Ze Chinese Herbal Pieces Co., Ltd. do not meet the requirements, and the items that do not meet the requirements are all properties. The 1 batch of Peucedanum peucedanum produced by anguo city Tongkang Pharmaceutical Co., Ltd. was tested by Dalian Institute for Drug Inspection and Quarantine, and the items that did not meet the requirements were characteristics and identification. After inspection by Shanxi Food and Drug Inspection Institute, 1 batch of Gentiana macrophylla marked as produced by Hunan Zirantang Chinese Herbal Pieces Co., Ltd. did not meet the requirements, and the nonconformities were characterized.